Market cap
$32,953 Mln
Revenue (TTM)
$5,653 Mln
P/E Ratio
22.1
P/B Ratio
5.1
Div. Yield
1 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$1,523 Mln
-
ROE
0.2 %
-
ROCE
21.4 %
-
Industry P/E
--
-
EV/EBITDA
15.2
-
Debt to Equity
0.1
-
Book Value
$45.4
-
EPS
$10.5
-
Face value
--
-
Shares outstanding
144,252,306
10 Years Aggregate
CFO
$5,283.93 Mln
EBITDA
$8,240.34 Mln
Net Profit
$4,886.20 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ResMed (RMD)
| -0.2 | 18.3 | 16.6 | -14.8 | 14.3 | -3.5 | 13.3 |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P 100
| 10.3 | 5.0 | 2.3 | 18.8 | 22.8 | 13.0 | 14.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
ResMed (RMD)
| 5.3 | 32.6 | -17.3 | -20.1 | 22.5 | 37.2 | 36.1 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
ResMed (RMD)
|
240.3 | 32,953.0 | 5,653.4 | 1,523.3 | 34.5 | 24.3 | 22.1 | 5.1 |
| 112.5 | 201,831.9 | 46,585.0 | 5,425.0 | 13.3 | 10.5 | 36.9 | 3.9 | |
| 189.5 | 51,105.2 | 20,839.0 | 941.0 | 6.9 | 3.8 | 32.5 | 2.1 | |
| 46.8 | 71,548.5 | 20,996.0 | 3,667.0 | 20.1 | 14.9 | 21 | 3.0 | |
| 216.1 | 151,781.7 | 25,107.0 | 4,004.0 | 20.1 | 7.6 | 37.7 | 2.8 | |
| 90.2 | 51,701.1 | 6,512.3 | 1,004.9 | 13.8 | 9.6 | 53.4 | 4.9 | |
| 555.0 | 43,875.6 | 4,553.2 | 1,139.7 | 32.1 | 70.8 | 39.1 | 27.2 | |
| 372.6 | 135,719.3 | 11,034.4 | 3,138.8 | 33.8 | 17.3 | 42.9 | 7.7 | |
| 330.7 | 125,696.9 | 25,837.0 | 3,729.0 | 14.5 | 16.1 | 35.2 | 5.4 | |
| 622.2 | 232,034.9 | 46,336.0 | 6,978.0 | 18.6 | 13.1 | 33 | 4.3 |
Shareholding Pattern
View DetailsAbout ResMed (RMD)
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep... recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. Read more
-
CEO & Chairman
Mr. Michael J. Farrell BE, MBA, SM
-
CEO & Chairman
Mr. Michael J. Farrell BE, MBA, SM
-
Headquarters
San Diego, CA
-
Website
FAQs for ResMed (RMD)
What is the current share price of ResMed Inc (RMD) Today?
The share price of ResMed Inc (RMD) is $240.33 (NYSE) as of 28-Aug-2026 16:00 EDT. ResMed Inc (RMD) has given a return of 14.29% in the last 3 years.
What is the current PB & PE ratio of ResMed Inc (RMD)?
The P/E ratio of ResMed Inc (RMD) is 22.11 times as on 21-Aug-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
18.55 |
4.29 |
2025 |
27.08 |
6.36 |
2024 |
27.66 |
5.81 |
2023 |
35.92 |
7.81 |
2022 |
39.54 |
9.17 |
What is the 52 Week High and Low of ResMed Inc (RMD)?
The 52-week high and low of ResMed Inc (RMD) are Rs 284.87 and Rs 180.27 as of 30-Aug-2026.
What is the market cap of ResMed Inc (RMD)?
ResMed Inc (RMD) has a market capitalisation of $ 32,953 Mln as on 21-Aug-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in ResMed Inc (RMD)?
Before investing in ResMed Inc (RMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.